“Association of Ruxolitinib Cream Initiation With Continued Reduction in Use of Other Topical Treatments, Oral Corticosteroids, and Biologics for Atopic Dermatitis” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s455. doi:10.25251/skin.8.supp.455.